167 related articles for article (PubMed ID: 11279166)
21. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
22. Stat5 is a physiological substrate of the insulin receptor.
Chen J; Sadowski HB; Kohanski RA; Wang LH
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2295-300. PubMed ID: 9122188
[TBL] [Abstract][Full Text] [Related]
23. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.
Peltola KJ; Paukku K; Aho TL; Ruuska M; Silvennoinen O; Koskinen PJ
Blood; 2004 May; 103(10):3744-50. PubMed ID: 14764533
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
25. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells.
Baetz A; Frey M; Heeg K; Dalpke AH
J Biol Chem; 2004 Dec; 279(52):54708-15. PubMed ID: 15491991
[TBL] [Abstract][Full Text] [Related]
26. The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells.
Rønn SG; Hansen JA; Lindberg K; Karlsen AE; Billestrup N
Mol Endocrinol; 2002 Sep; 16(9):2124-34. PubMed ID: 12198248
[TBL] [Abstract][Full Text] [Related]
27. 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells.
Morales O; Faulds MH; Lindgren UJ; Haldosén LA
J Biol Chem; 2002 Sep; 277(38):34879-84. PubMed ID: 12107179
[TBL] [Abstract][Full Text] [Related]
28. Tissue-specific induction of SOCS gene expression by PRL.
Tam SP; Lau P; Djiane J; Hilton DJ; Waters MJ
Endocrinology; 2001 Nov; 142(11):5015-26. PubMed ID: 11606470
[TBL] [Abstract][Full Text] [Related]
29. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
Dey BR; Furlanetto RW; Nissley P
Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
31. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.
Senn JJ; Klover PJ; Nowak IA; Zimmers TA; Koniaris LG; Furlanetto RW; Mooney RA
J Biol Chem; 2003 Apr; 278(16):13740-6. PubMed ID: 12560330
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
Zhou YC; Waxman DJ
J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
[TBL] [Abstract][Full Text] [Related]
33. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
34. A prostaglandin f(2alpha) analog induces suppressors of cytokine signaling-3 expression in the corpus luteum of the pregnant rat: a potential new mechanism in luteolysis.
Curlewis JD; Tam SP; Lau P; Kusters DH; Barclay JL; Anderson ST; Waters MJ
Endocrinology; 2002 Oct; 143(10):3984-93. PubMed ID: 12239110
[TBL] [Abstract][Full Text] [Related]
35. Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation.
Hong-Brown LQ; Brown CR; Cooney RN; Frost RA; Lang CH
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E63-72. PubMed ID: 12644450
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
Cacalano NA; Sanden D; Johnston JA
Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
[TBL] [Abstract][Full Text] [Related]
37. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression.
Storz P; Döppler H; Horn-Müller J; Groner B; Pfizenmaier K; Müller G
Anal Biochem; 1999 Dec; 276(1):97-104. PubMed ID: 10585749
[TBL] [Abstract][Full Text] [Related]
38. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
Ueki K; Kondo T; Kahn CR
Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
[TBL] [Abstract][Full Text] [Related]
39. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
40. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.
van de Geijn GJ; Gits J; Aarts LH; Heijmans-Antonissen C; Touw IP
Blood; 2004 Aug; 104(3):667-74. PubMed ID: 15069015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
